Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Structure Therapeutics Inc (GPCR)

Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Structure Therapeutics Inc 601 GATEWAY BLVD. SUITE 900 SOUTH SAN FRANCISCO CA 94080 USA

www.structuretx.com Employees: 93 P: 650-457-1978

Description:

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat chronic metabolic and pulmonary diseases with unmet medical needs. Structure Therapeutics Inc. is based in SAN FRANCISCO.

Key Statistics

Overview:

Market Capitalization, $K 1,913,090
Enterprise Value, $K 1,783,300
Shares Outstanding, K 57,261
Annual Sales, $ 0 K
Annual Net Income, $ -89,620 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -33,980 K
EBIT, $ -142,170 K
EBITDA, $ -147,850 K
60-Month Beta -3.23
% of Insider Shareholders 9.43%
% of Institutional Shareholders 91.78%
Float, K 51,861
% Float 90.57%
Short Volume Ratio 0.26

Growth:

1-Year Return -34.96%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 11/13/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -0.74
EPS Growth vs. Prev Qtr -11.11%
EPS Growth vs. Prev Year 4.76%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GPCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -16.37%
Return-on-Assets % -15.68%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.92
Book Value/Share 15.68
Interest Coverage -1.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar